AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.520
+0.004 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
0.536
+0.016 (3.00%)
Pre-market: Apr 29, 2026, 4:08 AM EDT
AIM ImmunoTech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -13.96 | -17.32 | -28.96 | -19.45 | -19.13 | |
| Depreciation & Amortization | 0.21 | 0.25 | 0.24 | 0.26 | 0.78 | |
| Other Amortization | 0.55 | 0.3 | - | - | 0.05 | |
| Loss (Gain) From Sale of Assets | - | - | -0.02 | - | -0.22 | |
| Asset Writedown & Restructuring Costs | 1.14 | 0.05 | 0.01 | - | 1.78 | |
| Loss (Gain) From Sale of Investments | -0.02 | 0.09 | -0.2 | 1.68 | 0.05 | |
| Stock-Based Compensation | 0.06 | 0.69 | 0.24 | 0.95 | 1.57 | |
| Other Operating Activities | 1.94 | 0.76 | 0.29 | -0.52 | 0.27 | |
| Change in Accounts Receivable | -0.01 | - | - | - | 0.03 | |
| Change in Accounts Payable | -1.71 | -0.06 | 6.07 | 0.18 | -0.19 | |
| Change in Other Net Operating Assets | 0.84 | 0.36 | 1.07 | 0.79 | 1.05 | |
| Operating Cash Flow | -10.96 | -14.89 | -21.27 | -16.11 | -13.97 | |
| Capital Expenditures | - | -0.02 | - | -0.09 | -0.04 | |
| Sale of Property, Plant & Equipment | - | - | 0.05 | 3.9 | 0.25 | |
| Sale (Purchase) of Intangibles | -0.38 | -0.54 | -0.59 | -0.19 | -0.59 | |
| Investment in Securities | 2.23 | 5.26 | -0.29 | 7.36 | -0.24 | |
| Investing Cash Flow | 1.85 | 4.71 | -0.83 | 10.99 | -0.63 | |
| Long-Term Debt Issued | 2.75 | 2.5 | - | - | - | |
| Long-Term Debt Repaid | -0.66 | -0.25 | - | - | -4.85 | |
| Net Debt Issued (Repaid) | 2.09 | 2.25 | - | - | -4.85 | |
| Issuance of Common Stock | 0.98 | 0.89 | 0.49 | 0.08 | 13.04 | |
| Other Financing Activities | 7.31 | 3.3 | - | - | - | |
| Financing Cash Flow | 10.39 | 6.44 | 0.49 | 0.08 | 8.19 | |
| Net Cash Flow | 1.28 | -3.74 | -21.61 | -5.04 | -6.41 | |
| Free Cash Flow | -10.96 | -14.91 | -21.27 | -16.19 | -14.01 | |
| Free Cash Flow Margin | -12451.14% | -8768.24% | -10528.22% | -11485.11% | -10374.81% | |
| Free Cash Flow Per Share | -6.77 | -26.61 | -43.73 | -33.67 | -29.56 | |
| Cash Interest Paid | 0.25 | - | - | - | - | |
| Levered Free Cash Flow | -11.97 | -12.2 | -12.16 | -11.15 | -9.77 | |
| Unlevered Free Cash Flow | -12.01 | -12.13 | -12.16 | -11.15 | -9.78 | |
| Change in Working Capital | -0.88 | 0.3 | 7.13 | 0.97 | 0.9 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.